ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 67 filers reported holding ALBIREO PHARMA INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $22 | -100.0% | 1,004 | -94.0% | 0.00% | -80.0% |
| Q3 2022 | $324,000 | +548.0% | 16,732 | +560.6% | 0.01% | +400.0% |
| Q2 2022 | $50,000 | +16.3% | 2,533 | +73.9% | 0.00% | – |
| Q1 2022 | $43,000 | -21.8% | 1,457 | -38.4% | 0.00% | -100.0% |
| Q4 2021 | $55,000 | -53.8% | 2,367 | -38.1% | 0.00% | -66.7% |
| Q3 2021 | $119,000 | +164.4% | 3,821 | +201.6% | 0.00% | +200.0% |
| Q2 2021 | $45,000 | -37.5% | 1,267 | -38.1% | 0.00% | 0.0% |
| Q1 2021 | $72,000 | -23.4% | 2,047 | -18.9% | 0.00% | -66.7% |
| Q4 2020 | $94,000 | -79.7% | 2,525 | -81.8% | 0.00% | -40.0% |
| Q3 2020 | $463,000 | +561.4% | 13,864 | +424.6% | 0.01% | +66.7% |
| Q2 2020 | $70,000 | +483.3% | 2,643 | +325.6% | 0.00% | +200.0% |
| Q3 2019 | $12,000 | +71.4% | 621 | +167.7% | 0.00% | – |
| Q1 2019 | $7,000 | -56.2% | 232 | -65.6% | 0.00% | -100.0% |
| Q4 2018 | $16,000 | – | 674 | +11133.3% | 0.00% | – |
| Q3 2018 | $0 | -100.0% | 6 | -99.4% | 0.00% | -100.0% |
| Q2 2018 | $34,000 | +1600.0% | 955 | +1369.2% | 0.00% | – |
| Q4 2017 | $2,000 | +100.0% | 65 | +54.8% | 0.00% | – |
| Q3 2017 | $1,000 | – | 42 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
| Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
| Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
| Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
| Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
| Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
| APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
| Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
| Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |